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Abstract: The objective was primarily to describe short term intra-individual variation in serum levels of soluble adhesion 
molecules (sCAMs: E-selectin, P-selectin, intercellular adhesion molecule-1(sICAM-1) and vascular cellular adhesion 
molecule-1(sVCAM-1)) in healthy subjects. Secondly, sCAMs were correlated to brachial artery ﬂ  ow mediated vasodilation 
(FMD).
Forty healthy subjects aged 24–66 years had sCAMs measured twice with 4 week intervals and short-term intra-individual 
variation was estimated as variation in the paired measurements after correcting for the analytical precision of the used 
method. At baseline, brachial FMD was measured.
No difference was observed in mean sCAMs in the whole study group. Estimated intra-subject variations in sCAMs were 
7.6–11.3%. In a regression analysis, signiﬁ  cant negative association was found between sE-selectin and FMD after control-
ling for possible confounders (p   0.04) while no signiﬁ  cant correlation could be demonstrated between the other sCAMs 
and FMD.
In conclusion, short term intra-individual variations in sCAMs were 7.6–11.3% in healthy subjects. We also found a sig-
niﬁ  cant negative association between sE-selectin and FMD, indicating an possible association between inﬂ  ammation and 
dysfunction of the vascular endothelium; however further studies are required to conﬁ  rm this preliminary ﬁ  nding.
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Introduction
The recruitment, adhesion and subsequent transendothelial migration of circulating leucocytes is impor-
tant in the initiation and progression of atherosclerosis (Ross, 1999). These processes are mediated by 
cellular adhesion molecules expressed by the vascular endothelium. Among these are vascular cell 
adhesion molecule-1 (VCAM-1), intercellular cell adhesion molecule-1 (ICAM-1), E- and P-selectins. 
The biological active molecules are trans-membrane proteins, but soluble forms of adhesion molecules 
(sCAMs) can be measured in plasma. sCAMs are elevated in subjects with traditional risk factors for 
developing cardiovascular disease (CVD), i.e. hypertension, diabetes, smoking, obesity and dyslipidemia 
(Celermajer et al. 1993; Chae et al. 2001; Clausen et al. 2000; Straczkowski et al. 2002; Winkelmann 
et al. 2001). Furthermore, sCAMs are also elevated in autoimmune diseases and in malignant diseases 
(Dedrick, Bodary and Garovoy, 2003; Kobayashi, Boelte and Lin, 2007; Witkowska and Borawska, 
2004).
The biological variability of sCAMs needs to be known and be low enough to enable reliable risk 
stratiﬁ  cation. The intra-individual variability in serum levels of sCAMs has not previously to our 
knowledge been investigated in detail.
Flow mediated vasodilation (FMD) in the brachial artery is a non-invasive method to access 
endothelial function. FMD correlate negatively with known risk factors of CVD, such as dyslipid-
emia, diabetes, hypertension, smoking (Celermajer, Sorensen, Georgakopoulos, Bull, Thomas, 
Robinson and Deanﬁ  eld, 1993), adiposity (Brook et al. 2001), and a familial history of CVD 
(Celermajer et al. 1994). Furthermore, FMD may have prognostic information about future CVD 
events (Gokce et al. 2003).
In the present study, we have investigated the short time variation in sCAMs in healthy volunteers 
and (as a pilot study) correlated FMD to plasma levels of sCAMs.58
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Methods
Study population
Forty healthy subjects were recruited from the 
medical staff, bank employees and students from 
Aalborg, Denmark. None of the volunteers took 
any medication or had any known disease. The 
procedures followed were in accordance with the 
ethical standards of the responsible Regional Com-
mittee on Human Experiments and in accordance 
with the Helsinki Declaration of 1975 as revised 
in 1983. All subjects gave written informed 
consent.
Measurement of adhesion molecules
Blood samples were taken from the left cubital 
vein twice with an interval of 4 weeks (and in all 
women at the same time of menstrual cycle). 
Venous blood was collected between 08:00 h and 
09:30 h after fasting overnight for at least 10 hours. 
Blood samples were allowed to clot for 1 hour at 
room temperature, and serum collected after cen-
trifugation at 2500 × g for 20 minutes and stored 
at −80 °C until analysis. Determination of serum 
levels of VCAM-1, ICAM-1, E-selectin and 
P-selectin were performed using commercially 
available test-kits (From R&D Systems Europe, 
Ltd.: Catalogue Numbers: DVC00 (sVCAM-1), 
BBE 1B (sICAM-1), BBE 6(sP-selectin), BBE 2B 
(sE-selectin)). Analysis was performed as batch-
operation using the same analysis-kit. The samples 
were analyzed twice and the average of the two 
measurements is reported.
Flow mediated dilation
Subjects were fasting overnight and instructed to 
abstain from tobacco smoking and coffee. After 
blood samples had been drawn from the left arm, 
subjects were placed supine at rest for 15 minutes 
in a quiet room at normal room temperature. A 
continuous ECG was recorded for timing of mea-
surements. The right radial artery was imaged in a 
longitudinal section 3 cm below the antecubital 
fossa. The probe was held in a constant position 
by a stereotactic clamp. Baseline dimensions were 
recorded at the center of the vessel with optimal 
contrast between the anterior and posterior vessel 
wall and the lumen. Doppler blood ﬂ  ow images 
were recorded from the center of the vessel. Then 
an arterial occlusion cuff, placed above the ante-
cubital fossa was inﬂ  ated to 300 mmHg for ﬁ  ve 
minutes. Immediately after deﬂ  ation of the cuff, a 
continuous 90 seconds recording of blood ﬂ  ow and 
vessel dimensions was obtained. The peak diam-
eter of the artery was recorded 60 seconds after 
deﬂ  ation of the cuff, and the percentage change 
from the baseline diameter was calculated.
Statistical analysis
Analyses were conducted using STATA statistical 
software, version 9.1. Short term variation in 
sCAMs was estimated by a paired t-test and coef-
ficient of variance was calculated as standard 
deviation of differences between paired measure-
ments divided mean difference in sCAMs within-
subjects (in sCAMs between baseline and after 4 
weeks). Analytical precision was calculated as a 
coefﬁ  cient of variation based on double measure-
ments of all blood samples taken at baseline and 
after 4 weeks (80 double measurements).
Pearson’s correlation coefﬁ  cient was used as a 
measure of linear association. Linear regression 
analysis was conducted to correct for possible 
confounding effects. Age was included as a 
numerical variable and age-groups as an indicator 
variable, allowing for non-linear relation between 
age and sCAMs. Body Mass Index, serum total 
cholesterol, systolic blood pressure were included 
as numerical variables and (current) smoking 
status and gender as indicator variables. A p-value 
 0.05 (two tailed) was considered statistically 
signiﬁ  cant.
Results
Characteristics of the forty participants are given 
in Table 1. No signiﬁ  cant correlation was found 
between either sCAMs or FMD and blood pressure, 
BMI, age and serum lipids and lipoproteins. Sig-
niﬁ  cant correlation was found between sP-selectin 
and sE-selectin (r = 0.82, p   0.001).
Short term variations in adhesion 
molecules
The results of measurements of sCAMs with four 
weeks interval are given in Table 2, and the calcu-
lated CVstudy% of the measurements is given. Also 
the table provides an estimate of the intra-individual 
variation, CVintra-subject% (the best estimate of intra-
individual short-time variation), based on the 
assumption that the measured CVstudy% consists 59
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of two components: variation (analytical precision) 
of the assay (CVanalytical) and variation in the differ-
ence between the paired measurements (intra-indi-
vidual, CVintra-subject). Then intra-individual 
variation were calculated using CVstudy
2 = CVana-
lytical
2 + CVintra-subject
2. Overall, the CVintra-subject% for 
each sCAM was between 7.6–11.3%.
Cellular adhesions molecules 
and ﬂ  ow mediated dilatation
No signiﬁ  cant correlations were found between 
FMD and each of sCAM, systolic blood pressure, 
BMI, smoking habits, lipids and lipoproteins or age. 
By gender, scatter plots of the data revealed that 
the variability were higher in the females (data not 
shown). Variation also increased with age. There-
fore, a regression analysis was performed with 
FMD as independent variable and sCAMs, gender 
and age. Age was included both as a numerical 
variable and with two age groups according to 
median age (51 years) as an indicator variable, 
allowing for non-linear relation between age and 
sCAMs. This effect remained significant after 
including following dependent variables (possible 
confounders): serum total cholesterol, BMI, systolic 
blood pressure and smoking habits. The results of 
the regression analysis are given in Table 3. A scat-
ter plot of sE-selectin and FMD divided according 
to median age is given in Figure 1.
Discussion
sCAMs may become a routinely used risk marker 
of preclinical atherosclerosis and therefore infor-
mation about the within-subject biological varia-
tion is essential. In the present study, our primary 
objective was to estimate within-subject short term 
biological variation in serum level of sCAMs in 
healthy volunteers. The estimated within-subject 
variation coefﬁ  cients were between 7.6–11.3% for 
all measured sCAMs. The difference in the study 
population mean serum sCAMs was negligible 
(less than 1%) in samples taken 4 weeks apart. Also 
analytical precision of commercially available 
analysis assays is excellent (CV% of approxi-
mately 2%). We have no knowledge of other stud-
ies investigating the short term variation in sCAMs 
under standardized conditions. However, variations 
in sCAMs have been investigated both as diurnal 
variations and variation due to physical or psycho-
logical stress. The diurnal intra-subject variation 
in sCAMs in healthy subjects and in patients with 
CHD have been reported for P-selectin, ICAM-1 
and E-selectin (Osmancik et al. 2004); only 
P-selectin showed signiﬁ  cant diurnal variation 
(highest in the evening). Effects of factors such a 
physical or psychological stress may also induce 
Table 1. Population characteristics at baseline.
Gender (male/female, n)  20/20
Age (years)  48.4 ± 12
BMI (kg/m
2) 24.0 ± 3
Current smokers (n (percent))  9 (23)
Systolic BP (mmHg)  115 ± 10
Diastolic BP (mmHg)  74 ±  7
Creatinine (μmol/l) 81 ± 13
Fasting glucose (mM)  4.4 ± 0.4
Total cholesterol (mM)  5.2 ± 1.3
Triglycerides (mM)  1.1 ± 0.5
HDL-cholesterol (mM)  1.4 ± 0.3
LDL-cholesterol (mM)  3.3 ± 1.2
sICAM-1 (ng/l)  233 ± 114
sVCAM-1 (ng/l)  515 ± 103
sP-selectin (ng/l)  25 ± 8
sE-selectin (ng/l)  43 ± 15
FMD (percent change)  9.6 ± 4.1
Exact number or mean ± SD.
Table 2. Short-time variation in soluble cellular adhesion molecules in 40 healthy subjects (samples taken with 
4 weeks interval).
 VCAM-1  P-selectin  E-selectin  ICAM-1
Mean tBaseline  515 ± 103 25.0 ± 8.5 42.8 ± 15.4 233 ± 115
Mean t4 weeks  515 ± 119 24.5 ± 8.6 42.7 ± 16.5 232 ± 106
Difference ± SD 0.60 ± 49 0.50 ± 2.8 0.10 ± 4.8 0.53 ± 18
CV% 9.6  11.5  11.3  7.9
Analytical CV%
† 1.4  2.0  2.1  2.1
Intra-individual CV%
‡ 9.5  11.3  11.1  7.6
Mean ± SD. 
†Based on double measurements of all samples.
‡Estimated (from: CVstudy
2 = CVanalytical
2 + CVintra-subject
2).60
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within-subject variations in serum levels of sCAMs 
of approximately 10% (Dugue, Leppanen and 
Grasbeck, 1999). Thus, the result may have impli-
cations for studies evaluating sCAMs as a marker 
of risk. An important parameter to consider in the 
design of clinical trials assessing systemic low 
grade inﬂ  ammation in atherosclerosis is the degree 
of within-subject biological variation. One way to 
reducing the inherent variability of the technique 
might be repeated measurements of sCAMs due 
to the effect of reducing the SD and thereby the 
sample size estimates. Indeed, our results indicate 
that repeated measurements of sCAMs may be 
preferable as the short term intra-individual varia-
tion is approximately 10 percent.
In the second part of our study we aimed to 
investigate an association between two important 
aspects in the progression of atherosclerosis, that 
is the lowgrade endothelial/systemic inﬂ  ammation 
and the endothelial dysfunction. There is little 
knowledge of interrelations between FMD and 
sCAMs in healthy individual. In contrast, several 
reports have related either FMD or sCAMs to the 
presence of traditional risk factors for CVD, such 
as dyslipidemia, diabetes (Clausen, Jacobsen, 
Rossing, Jensen, Parving and Feldt-Rasmussen, 
2000; Ravikumar et al. 2002), hypertension (Chae, 
Lee, Rifai and Ridker, 2001; Park, Charbonneau 
and Schiffrin, 2001), smoking (Celermajer, 
Sorensen, Georgakopoulos, Bull, Thomas, Robin-
son and Deanﬁ  eld, 1993; Winkelmann, Boehm, 
Nauck, Kleist, Marz, Verho, Ranjith and Kneissl, 
2001), and adipositas (Brook, Bard, Rubenﬁ  re, 
Ridker and Rajagopalan, 2001; Straczkowski, 
Lewczuk, Dzienis-Straczkowska, Kowalska, 
Stepien and Kinalska, 2002). In our study, sE-
selectin correlated to FMD. In contrast, Witte 
(Witte et al. 2003) reported that sICAM-1 and 
FMD in the brachial artery correlated in 166 
healthy individuals, and they also reported that 
both sICAM-1 and FMD related to the estimated 
risk of CVD. They did not measure sE-selectin, 
sP-selectin or sVCAM-1. The reasons for this 
discrepancy is not clear, but in the study but Witte 
et al. more subject were included. (In our study, 
the association between sICAM-1 and FMD came 
close to signiﬁ  cance with a p-value = 0.11). E-
selectin is exclusively expressed on endothelial 
cells (Roldan et al. 2003), in contrast to sP-selectin, 
sICAM-1 and sVCAM-1. Perhaps sE-selectin is a 
Table 3. Regression analysis with Flow Mediated 
Vasodilation as independent variable and soluble Cel-
lular Adhesion Molecules, gender, age groups, systolic 
blood pressure, serum total cholesterol, Body Mass 
Index and smoking habits as dependent variables.
 Flow  Mediated  Vasodilation
 (percent  change)
 Coefﬁ  cient  s.d.  t  p-value
 beta
sICAM-1
†  −0.047 0.02  −1.61 0.12
sVCAM-1
†  −0.007 0.01  −0.59 0.56
sP-selectin
†  −0.014 0.16  −0.88 0.38
sE-selectin
†  −0.16 0.08  −2.06 0.04
†ng/l. Only coefﬁ  cients for cellular adhesion molecules are given.
sE-selectin (ng/L)
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Figure 1. Scatterplot of sE-selection and Flow Mediated Vasodilation (FMD) in the study population dichotomized according to median age.61
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more speciﬁ  c marker of inﬂ  ammation in vascular 
endothelium, because both ICAM-1 and VCAM-1 
are expressed on several other cells (e.g. inﬂ  am-
matory leucocytes, smooth muscle cells) and 
therefore they might be more general markers of 
universal low grade systemic inﬂ  ammation (Blan-
kenberg, Barbaux and Tiret, 2003). The major 
source of sP-selectin is believed to be activated 
platelets (Blann, Nadar and Lip, 2003), though 
sP-selectin is also expressed by the activated endo-
thelium. We found a close signiﬁ  cant correlation 
between sP-selectin and sE-selectin. However, 
after controlling for possible confounders sP-
selectin did not correlate to FMD. In early athero-
sclerosis, also endothelial P-selectin expression is 
crucial in the progression of the atherosclerotic 
lesion(Burger and Wagner, 2003), and therefore 
this close link between endothelial activation (and 
E-selectin expression) and sP-selectin was 
expected. The interrelations between sCAMs and 
endothelial vasodilatory function in healthy subject 
have been investigated by strain-gauge venous 
occlusion plethysmography. Holmlund (Holmlund 
et al. 2002) reported that only sICAM-1 but not 
sE-selectin or sVCAM-1 correlated to endothelial 
vasodilatory function in 59 healthy subjects. This 
contrasts our ﬁ  ndings. However, both studies indi-
cate that endothelial vasodilatory function and 
markers of endothelial inﬂ  ammation are correlated. 
This also fits the findings that both sCAMs 
(Blankenberg, Barbaux and Tiret, 2003; Ridker 
et al. 1998; Ridker, Buring and Rifai, 2001) and 
FMD (Gokce, Keaney, Jr., Hunter, Watkins, 
Nedeljkovic, Menzoian and Vita, 2003) may have 
prognostic information about future CVD.
Limitations of our study are primarily the small 
number of subjects under investigation. However, 
the differences in sCAMs between within subject 
paired measurements showed good approximation 
to a normal distribution. Population size was of 
greater importance in the investigation of a pos-
sible association between sCAMs and FMD. 
Because data analysis revealed a marked age-
dependency and marked gender dependency on the 
association between sCAMs and FMD, a regres-
sion analysis including possible confounders were 
performed. However, care should be taken to make 
ﬁ  rm conclusions based on this part of the study. 
This part of our study should only be viewed as a 
pilot study. A large scale study is required to estab-
lish an association between sCAMs and FMD.
In conclusion, short term intra-individual coef-
ﬁ  cients of variation in sCAMs in healthy subjects 
are estimated to be 7.6–11.3 percent under 
standardized condition. This intra-subject varia-
tion need consideration in evaluation of sCAMs 
in experimental trials and in clinical use. We also 
found a weak signiﬁ  cant negative correlation 
between sE-selectin and FMD, indicating an 
association of dysfunction and inﬂ  ammation in 
the vascular endothelium. However, due to the 
small population size, a larger study is required 
to establish possible association between FMD 
and sCAMs.
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